A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
require that children’s cosmetics containing talc include 
an appropriate warning unless the cosmetics are dem-
onstrated to be asbestos-free, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Children’s Product 
4
Warning Label Act of 2019’’. 
5
00:45 Apr 02, 2019
H1816
2 
•HR 1816 IH
SEC. 2. LABELING OF TALC IN CHILDREN’S COSMETICS. 
1
(a) MISBRANDING.—Section 602 of the Federal 
2
Food, Drug, and Cosmetic Act (21 U.S.C. 362) is amend-
3
ed by adding at the end the following: 
4
‘‘(g) If it is marketed for use in children (meaning 
5
individuals under the age of 18) and contains talc (as de-
6
fined in section 604) unless— 
7
‘‘(1) its label includes the following statement 
8
printed in conspicuous text: ‘WARNING: Talc in 
9
this product has not been evaluated for asbestos con-
10
tamination. Asbestos may be present. Asbestos at 
11
any level is known to the FDA to cause cancer, in-
12
cluding lung cancer and mesothelioma. This product 
13
is not suitable for use by children.’; or 
14
‘‘(2) a waiver is in effect with respect to the 
15
cosmetic pursuant to section 604.’’. 
16
(b) PREMARKET SAFETY VERIFICATION
OF TALC 
17
CONTENT.—Chapter VI of the Federal Food, Drug, and 
18
Cosmetic Act (21 U.S.C. 361 et seq.) is amended by add-
19
ing at the end the following: 
20
‘‘SEC. 604. PREMARKET SAFETY VERIFICATION OF TALC 
21
CONTENT. 
22
‘‘(a) IN GENERAL.—The Secretary shall waive the 
23
applicability of section 602(g)(1) with respect to a cos-
24
metic containing talc if the manufacturer of the cos-
25
metic— 
26
00:45 Apr 02, 2019
H1816
3 
•HR 1816 IH
‘‘(1) attests in writing to the Secretary that the 
1
source of the talc is an asbestos-free mine; and 
2
‘‘(2) demonstrates to the Secretary that the talc 
3
is asbestos-free using the transmission electron mi-
4
croscopy method. 
5
‘‘(b) DEFINITIONS.—In this section: 
6
‘‘(1) The term ‘asbestos’ means the asbestiform 
7
varieties of chrysotile (serpentine), crocidolite (rie-
8
beckite), amosite (cummingtonitegrunerite), antho-
9
phyllite, tremolite, and actinolite. 
10
‘‘(2) The term ‘asbestos-free’ means containing 
11
no traceable asbestos fibers. 
12
‘‘(3) The term ‘talc’— 
13
‘‘(A) means a basic silicate of magnesium; 
14
and 
15
‘‘(B) includes talcum powder, hydrous 
16
magnesium silicate, non-fibrous talc, non-as-
17
bestiform talc, steatite talc, and fibrous non- 
18
tremolite talc. 
19
‘‘(4) The term ‘transmission electron micros-
20
copy’ refers to the asbestos analysis method used by 
21
laboratories that— 
22
‘‘(A) are accredited by the National Bu-
23
reau of Standards; and 
24
00:45 Apr 02, 2019
H1816
4 
•HR 1816 IH
‘‘(B) use the protocol described in appen-
1
dix A to subpart E of part 763 of title 40, Code 
2
of Federal Regulations (or any successor regu-
3
lations).’’. 
4
(c) APPLICABILITY.—Sections 602(g) and 604 of the 
5
Federal Food, Drug, and Cosmetic Act, as added by sub-
6
sections (a) and (b), apply beginning on the date that is 
7
180 days after the date of enactment of this Act. 
8
(d) REGULATIONS.—Not later than 180 days after 
9
the date of enactment of this Act, the Secretary of Health 
10
and Human Services, acting through the Commissioner of 
11
Food and Drugs, shall promulgate final regulations to im-
12
plement such sections 602(g) and 604. 
13
Æ 
00:45 Apr 02, 2019
H1816
